关节炎治疗耐受性 (RTCure) - - 一个IMI项目,旨在预防和治愈RA
Lars Klareskog1, 1
1Department of Medicine, Rheumatology Division, Karolinska Institutet, Stockholm Sweden.
Seminars in arthritis and rheumatism
|November 25, 2023
概括
该RT Cure项目推进了对适应性免疫的理解,以预测类风湿性关节炎 (RA) 风险. 这些知识支持使用向免疫疗法预防RA的临床试验.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 翻译医学是一种翻译医学.
背景情况:
- 由创新药物倡议 (IMI) 资助的RT Cure项目是一个为期6年的合作项目,涉及欧洲和澳大利亚的风湿病学机构和制药公司.
- 了解适应性免疫系统在类风湿性关节炎 (RA) 发病过程中的作用,对于制定有效的预防和治疗策略至关重要.
研究的目的:
- 阐明适应性免疫在已确定的类风湿性关节炎 (RA) 之前和期间的特异性和调节.
- 为了利用这种理解来预测RA风险和建立患者队列.
- 通过免疫监测工具和知识支持针对RA预防的临床试验.
主要方法:
- 对风险较高的个体和已确定的类风湿性关节炎 (RA) 个体的适应性免疫的分析.
- 开发RA风险评估的预测模型.
- 建立RA-at-risk队列的注册表. 在风险队列中建立注册表.
- 实施免疫监测工具以支持临床试验.
主要成果:
- 获得了关于类风湿性关节炎 (RA) 适应性免疫的特异性和调节的新见解.
- 能够预测RA风险,并促进了风险RA队列的创建.
- 为成功的临床试验提供支持,重点关注RA预防.
结论:
- 该项目的研究结果为开发用于预防RA的新型特异性免疫疗法提供了基础.
- 了解免疫监测的持续进展将促进类风湿性关节炎 (RA) 的预防.
相关概念视频
Autoimmune Disorders
448
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
448
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management
130
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
130


